Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis

ClinicalTrials.gov ID: NCT04462536

Public ClinicalTrials.gov record NCT04462536. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 4:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this study is to determine if a single dose of nerinetide can reduce global disability in people who have had a stroke and are selected for endovascular therapy without the use of a tissue plasminogen activator (alteplase, tenecteplase, or equivalent).

Study identification

NCT ID
NCT04462536
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
NoNO Inc.
Industry
Enrollment
850 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 5, 2020
Primary completion
Aug 30, 2023
Completion
Aug 30, 2023
Last update posted
Jun 21, 2025

2020 – 2023

United States locations

U.S. sites
17
U.S. states
14
U.S. cities
17
Facility City State ZIP Site status
St. Joseph's Hospital & Medical Center Phoenix Arizona 85013
Providence Little Company of Mary Medical Center - Torrance Torrance California 90503
Swedish Medical Center Englewood Colorado 80113
Baptist Health Research Institute Jacksonville Florida 32207
University of Miami, Jackson Memorial Hospital Miami Florida 33136
Grady Memorial Hospital Atlanta Georgia 30303
University of Maryland Medical Center Baltimore Maryland 21201
University of Massachusetts Medical School Worcester Massachusetts 01655
NYU Langone Hospital Brooklyn Brooklyn New York 11220
Montefiore Medical Center The Bronx New York 10467
The Ohio State University, Wexner Medical Center Neurological Surgery Columbus Ohio 43203
Providence St. Vincent Medical Center Portland Oregon 97225
Abington Memorial Hospital Abington Pennsylvania 19001
UPMC Stroke Institute Pittsburgh Pennsylvania 15213
Rhode Island Hospital Providence Rhode Island 02903-4923
Valley Baptist Medical Center - Harlingen Harlingen Texas 78550
Swedish Medical Center - Cherry Hill Campus Seattle Washington 98122

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 64 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04462536, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 21, 2025 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04462536 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →